Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after hip or knee replacement: pooled analysis of the RE MOBILIZE, RE-MODEL and RE-NOVATE trials
Authors
Friedmann R, Dahl O, Francis C, Kurth A, Liebermann JR, Rosencher N, Clemens A, Hantel S, Schnee J, Eriksson BI, Caprini JA, for the RE-MODEL, RE-NOVATE and RE-MOBILIZE Steering Committees
Journal
Thrombosis Research
Publication Date
2010
Impact Factor
3.133
Abstract
Additional IDs
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after hip or knee replacement: pooled analysis of the RE MOBILIZE, RE-MODEL and RE-NOVATE trials - Publication by Dr. Andreas Clemens | Dr. Andreas Clemens